Bionest Partners is a global consulting firm focused on Pharma, Biotech, Medical Device and Diagnostics.

Read More

Communicating Value

In today’s political climate, pharmaceutical companies must think even harder about how to communicate the value that their therapies bring to patients.


Learn More

Orphans Should Live Alone

Read our recent article for In Vivo with advice for pharma interested in rare diseases.


Read More

How Immuno-Oncology Is Turning Biomarker Development On Its Head


Our latest article in In Vivo covers the challenges in orchestrating a biomarker program in immuno-oncology.


Read More

Chan Zuckerberg Initiative Funds $3 Billion Science Effort to Cure or Manage All Diseases by 2100

Rather than directing most of the efforts towards specific cures, the initiative is taking a long view and will fund basic research that addresses fundamental biological questions that may provide a foundation for future medical research.


Learn More

Moonshot: On its Way?

It remains to see what the priorities of the new Congress will be under President Trump.

Learn More

About Bionest

We help clients navigate complex product development and commercialization issues in order to drive growth, create value and gain competitive advantage. We also offer our expertise and analytic skills to support investors with due diligence assignments. Our deep content experience, combined with our collaborative and hands-on approach results in practical solutions that drive internal alignment at the corporate, portfolio, and brand levels.

News & Views

Check out our blog for news and commentary on the latest issues in pharma.